Raquel Miguéis
November 18, 2024

Annual Price Revision for 2025

Portaria n.º 293/2024/1 was published last week, on November 15th, defining the reference countries to be considered for price calculation and the criteria for annual price revision (RAP) of 2025.

The deadlines for RAP 2025 were also defined.

  • For non-generic medicinal products, new maximum prices must be submitted to INFARMED up to 15th December 2024, which will come into force in 1st January 2025.
  • For generic medicinal products, new maximum prices must be submitted to INFARMED up to 15th January 2025, which will come into force in 1st February 2025.

Informative Note and support documentation for RAP 2025 were also published in INFARMED’s website.

Owlpharma can support you in the preparation of Annual Price Revision. For more information, please contact us at owlpharma@owlpharma.pt.

Latest news

August 28, 2025

/

Cristina Serra

The Updated GACP Guideline: What's new? Connecting the Dots Between Farming and Pharma

August 13, 2025

/

Ana Rita Cordeiro

New Requirements for EudraVigilance Signal Monitoring under Implementing Regulation (EU) 2025/1466

August 11, 2025

/

Carolina Mesquita

Major Overhaul of EU Pharmacovigilance Rules: Key Changes Introduced by Implementing Regulation (EU) 2025/1466